OxThera, founded in 2005 and headquartered in Stockholm, Sweden, is a biopharmaceutical company with products in late-stage clinical development focusing on Primary and Secondary Hyperoxaluria. OxThera’s intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes.
| Website | http://www.oxthera.com |
| Revenue | $14 million |
| Employees | 8 (3 on RocketReach) |
| Founded | 2005 |
| Phone | +46 8 660 02 23 |
| Technologies |
JavaScript
,
HTML
,
PHP
+14 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Health Care, Health Diagnostics |
| Web Rank | 20 Million |
| Keywords | Kidney Stones, Renal Disease, Rare Diseases, Nephrology, Biopharmaceutical, Genetic Disorders, Metabolic Disorders, Clinical Development, Inborn Errors Of Metabolism, Drug Development, Pharmaceutical Research |
| Competitors | Roche, Novartis, AbbVie, Merck & Co., Inc., Pfizer, Sanofi, Amgen, Gilead Sciences, Vertex Pharmaceuticals, Receptos, a wholly-owned subsidiary of Celgene +45 more (view full list) |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies |
Looking for a particular OxThera employee's phone or email?
The OxThera annual revenue was $14 million in 2026.
3 people are employed at OxThera.
The NAICS codes for OxThera are [5417, 54, 54171, 541, 541714].
The SIC codes for OxThera are [873, 87].